Active Ingredient(S)
Olopatadine (0.1%).........(equivalent to olopatadine hydrochloride 0.111%)
The following Structured Product Label (SPL) was submitted to the FDA by Alembic Pharmaceuticals Inc. for the product Olopatadine Hydrochloride (NDC 62332-709). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient(s), purpose, use(s), warnings, do not use, when using this product, stop use and ask doctor if, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Olopatadine (0.1%).........(equivalent to olopatadine hydrochloride 0.111%)
Antihistamine and redness reliever
temporarily relieves itchy red eyes due to pollen, ragweed, grass, animal hair and dander
For external use only
• if solution changes color or becomes cloudy
• if you are sensitive to any ingredient in this product
• to treat contact lens related irritation
• do not touch tip of container to any surface to avoid contamination
• remove contact lenses before use
• wait at least 10 minutes before reinserting contact lenses after use
• do not wear a contact lens if your eye is red
you experience:
If swallowed, get medical help or contact a Poison Control Center right away.
• adults and children 2 years of age and older:
• put 1 drop in the affected eye(s) twice daily, every 6 to 8 hours, no more than twice per day
• if using other ophthalmic products while using this product, wait at least 5 minutes between each product
• replace cap after each use
• children under 2 years of age: consult a doctor
• only for use in the eye
• store between 4°C to 25°C (39°F to 77°F)
benzalkonium chloride 0.01%, dibasic sodium phosphate, hydrochloric acid/sodium hydroxide (adjust pH), sodium chloride, and water for Injection
Contact Alembic Pharmaceuticals Inc. at 1-866-210-9797
* Please review the disclaimer below.